Alternatives to Zarontin If You Can't Fill Your Prescription

Zarontin (ethosuximide) is the gold-standard first-line treatment for childhood absence epilepsy, backed by decades of clinical evidence. But if your pharmacy doesn't have it in stock—or the cost is a barrier—your neurologist may discuss alternative medications to bridge the gap.

This guide outlines the main alternatives to Zarontin, what the research says about their effectiveness, and important considerations for each. Always discuss any medication change with your neurologist before making a switch.

Why Zarontin Is the Preferred First-Line Option

A major randomized controlled trial published in the New England Journal of Medicine compared ethosuximide, valproic acid, and lamotrigine in 453 children with newly diagnosed absence epilepsy. At 12 months, seizure freedom rates were similar between ethosuximide (45%) and valproic acid (44%), both significantly higher than lamotrigine (21%). Crucially, ethosuximide had fewer adverse attentional effects than valproic acid, making it the preferred initial monotherapy.

This evidence guides neurologist decisions when Zarontin is unavailable. Here are the main alternatives they may consider:

Alternative 1: Valproic Acid (Depakote, Depakene)

Efficacy: Equivalent to ethosuximide for absence seizures, with 44% seizure-free at 12 months in the same landmark trial.

Advantages: More widely available and stocked at pharmacies. Broad-spectrum coverage is useful if the patient also has generalized tonic-clonic seizures alongside absence seizures.

Disadvantages: Higher rate of adverse events—33% of the valproic acid group in the clinical trial discontinued due to intolerable side effects compared to 25% for ethosuximide. Significant teratogenicity risk—valproic acid should be avoided in women of childbearing age. Also associated with weight gain, hair thinning, tremor, and liver toxicity monitoring requirements.

Best for: Patients with absence seizures plus other seizure types (generalized epilepsy syndromes); male patients where teratogenicity risk is not a concern.

Alternative 2: Lamotrigine (Lamictal)

Efficacy: Less effective than ethosuximide for absence seizures—only 21% seizure-free at 12 months versus 45% for ethosuximide in the landmark trial. Considered a second-line option.

Advantages: Generally well tolerated. Widely available and inexpensive. Preferred for women of childbearing age because of its better teratogenicity profile compared to valproic acid.

Disadvantages: Significantly lower seizure-control rates for absence epilepsy. Risk of serious skin rash (Stevens-Johnson syndrome) with rapid dose titration. Requires slow uptitration over weeks.

Best for: Women of childbearing age; patients with milder absence epilepsy or as add-on therapy; patients who cannot tolerate both ethosuximide and valproic acid.

Alternative 3: Clonazepam (Klonopin)

Efficacy: Benzodiazepine with some evidence for reducing absence seizures, though typically not used as a monotherapy first-line agent.

Disadvantages: Sedation, cognitive effects, and risk of tolerance and physical dependence limit long-term use. This is a Schedule IV controlled substance.

Best for: Short-term adjunctive use or bridge therapy while awaiting Zarontin supply.

Alternative 4: Clobazam (Onfi)

Efficacy: A benzodiazepine with some evidence for absence seizures, usually used as add-on therapy rather than monotherapy. Schedule IV controlled substance.

Best for: Adjunctive use in patients with difficult-to-control absence seizures who are already on other agents.

Key Questions to Ask Your Neurologist Before Switching

• Is there a formulation of Zarontin (capsules vs. oral solution) that might be available?
• Do I have generalized tonic-clonic seizures in addition to absence seizures? (Affects choice of alternative)
• Am I a woman of childbearing age? (Critical for valproic acid decision)
• How long will this alternative be needed? (Bridge vs. permanent switch)
• Will I need a drug level check or EEG when switching back to Zarontin?

Try to Find Zarontin First

Before switching to an alternative, it's worth making sure Zarontin truly isn't available near you. medfinder.com calls pharmacies near you to find which ones can fill your prescription. See our guide to how to find Zarontin in stock near you for more tips.